ITOCHU Technology Ventures
Finance · Japan · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Tokyo, Tokyo, JapanPhone Number
+81 2013042910Website
www.techv.co.jpRevenue
<$5 MillionIndustry
About ITOCHU Technology Ventures
ITOCHU Technology Ventures Org Chart
Is ITOCHU Technology Ventures your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on ITOCHU Technology Ventures recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if ITOCHU Technology Ventures has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once ITOCHU Technology Ventures has new funding data
Congratulate Masked Content for being promoted to Masked Content at ITOCHU Technology Ventures
Product Launch: Get notified when ITOCHU Technology Ventures launches new products
Website visits: Recent activity has been detected on your website
Check out if ITOCHU Technology Ventures is spiking on competitors!
ITOCHU Technology Ventures, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if ITOCHU Technology Ventures had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined ITOCHU Technology Ventures as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
ITOCHU Technology Ventures is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
ITOCHU Technology Ventures is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about ITOCHU Technology Ventures.
ITOCHU Technology Ventures Tech Stack
A closer look at the technologies used by ITOCHU Technology Ventures
Most Recent Scoops
ITOCHU Technology Ventures News & Media
OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology
TOKYO, July 20, 2021 /PRNewswire/ -- OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B financing led by The University of Tokyo Edge Capital...ThinkCyte Secures $26M in Series B Funding
ThinkCyte, a Tokyo, Japan-based company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, raised $26m in Series B funding. The round was led by SPARX Group, Sysmex Corporation, Sumitomo Mitsui Trust Investment, SBI Group and Itochu Technology Ventures. The company intends to use the funds to accelerate: the development of […] The post ThinkCyte Secures $26M in Series B Funding appeared first on FinSMEs.
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding ITOCHU Technology Ventures
ITV is a hybrid venture capital firm that combines the strengths of an independent VC with those of the Itochu Group. The company aims to create new industries and bring evolution to society through its investments. It focuses on fostering innovation and supporting startups that align with its vision. ITV serves a diverse range of clients, includin... Read More